Luvometinib
WCSH-NCP-SS-LCH-2026
Unknown small_molecule active
Quick answer
Luvometinib for Langerhans Cell Histiocytosis (LCH) is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Langerhans Cell Histiocytosis (LCH)
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active